||**Evexia Foundation**|**Evexia Foundation**|**Evexia Foundation**|**1176962**|**1176962**|**CC16a**|
|---|---|---|---|---|---|---|
||**For the period**<br>**from**|Period start date<br>01-Aug-23|**To**|Period end date<br>31-Jul-24|||
||||||||
|**Section A Receipts and payments**|||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**3,770.00**<br>**249.99**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br> <br> **4,019.99**<br>**-**<br>**-**<br> **-**<br>**4,020**<br>**176.00**<br>**1,344.75**<br>**-**<br>**528.00**<br>**112.50**<br>**178.20**<br>**-**<br>**-**<br> **2,339.45**<br>**-**<br>**-**<br> **-**<br>**2,339.45**<br>**1,680.54**<br>**-**<br>**5,767.25**<br>**7,447.79**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**450.00**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**450.00**<br>**-**<br>**-**<br>**-**<br>**450**<br>**-**<br>**75.00**<br>**300.00**<br>**-**<br>**200.00**<br>**-**<br>**175.00**<br>**-**<br>**-**<br>**750.00**<br>**-**<br>**-**<br>**-**<br>**750.00**<br>**-               300.00**<br>**-**<br>**300.00**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**<br>**3,770**<br>**250**<br>**450**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**4,470**<br>**-**<br>**-**<br>**-**<br>**4,470**<br>**176**<br>**1,420**<br>**300**<br>**-**<br>**728**<br>**113**<br>**353**<br>**-**<br>**-**<br>**3,089**<br>**-**<br>**-**<br>**-**<br>**3,089.45**<br> <br>**1,380.54**||**Last year**<br>**to the nearest £**|
|Donations|**3,770.00**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**3,770**||**-**|
|Bank compensation|**249.99**|||**250**||**-**|
|Grant|**-**|||**450**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
||**-**<br>|||**-**||**-**|
|~~**_Sub total_**~~~~_(Gross income for_~~<br>_AR)_|<br> **4,019.99**|||**4,470**||**-**|
||||||||
|**A2 Asset and investment sales,**<br>**(see table).**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**||**-**|
|**_Sub total_**|**-**|||**-**||**-**|
|**_Total receipts_**<br>**A3 Payments**|||||||
||||**-**|**4,470**||**-**|
||||||||
|<br>Website and IT costs|**176.00**||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**176**||**-**|
|Venue hire|**1,344.75**|||**1,420**||**-**|
|Equipment|**-**|||**300**||**-**|
|Teacher services||||**-**||**-**|
|Training/Research and Development|**528.00**|||**728**||**-**|
|Admin and Consultation|**112.50**|||**113**||**-**|
|Social media / Promo and Marketing|**178.20**|||**353**||**-**|
||**-**|||**-**||**-**|
||**-**|||**-**||**-**|
|**_Sub total_ **|**2,339.45**|||**3,089**||**-**|
||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**|||||||
||**-**||**-**<br>**-**<br>**-**|**-**|||
||**-**|||**-**|||
|**_Sub total_ **|**-**|||**-**||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**|||||||
||||**-**|**3,089.45**||**-**|
||||||||
||**1,680.54**|**-               300.00**|**-**|<br>**1,380.54**||**-**|
||**-**|**-**|**-**<br>**-**|**-**||**-**|
||**5,767.25**|**300.00**||**6,067.25**||**-**|
||**7,447.79**|**-**|**-**|**7,447.79**||**-**|



CCXX R1 accounts (SS) 

05/11/2024 

1 



|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**|**Section B Statement of assets and liabilities at the end of the period**||
|---|---|---|---|
|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**<br>CCXX R2 accounts (SS)|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>Bank<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>2|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**7,447.79**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**7,447.79**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Wendyvan der Haagen Boyd<br>ClareKenvyn|**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||||30th Oct 2024|
||||5th Nov 2024|
||||05/11/2024|



CCXX R2 accounts (SS) 

